NH - Swing Trade Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Swing Trade Rating: 4.4

📈 Technical & Momentum Analysis

Price Positioning: Current price ₹1,983 is above both 50 DMA (₹1,920) and 200 DMA (₹1,640) — bullish alignment.

RSI (52.1) — neutral to slightly bullish, room for upward movement.

MACD (11.7) — strong positive momentum signal.

Volume: Slightly below 1-week average — suggests consolidation, not weakness.

📊 Fundamental Overview

Valuation

P/E (50.9) vs Industry P/E (69.2) — premium valuation, but justified by growth.

PEG Ratio (1.61) — slightly high, but acceptable for growth stocks.

EPS (₹38.7) — strong earnings base.

Book Value (₹177) — price trades at ~11x book, typical for high-growth healthcare stocks.

Profitability

ROCE (20.6%) and ROE (24.5%) — excellent returns, strong operational efficiency.

Dividend Yield (0.23%) — minimal, typical for growth-focused companies.

Quarterly Performance

PAT Qtr: ₹203 Cr vs Prev Qtr: ₹194 Cr — steady growth (+7.8%).

Debt-to-Equity (0.67) — moderate leverage, manageable.

FII/DII Holding

FII up (+0.80%) — growing foreign interest.

DII down (-0.43%) — mild domestic caution.

✅ Swing Trade Strategy

Optimal Entry Price: ₹1,950–₹1,970 (near 50 DMA and support zone)

Target Exit Price: ₹2,150–₹2,200 (resistance zone below recent high of ₹2,372)

Stop Loss: ₹1,910 (below 50 DMA and psychological support)

🧭 If You Already Hold the Stock

Hold with a target of ₹2,150–₹2,200.

Exit if price breaks below ₹1,910 or RSI dips below 48 with MACD weakening.

This stock shows strong fundamentals and technical momentum, making it a solid candidate for swing trading with a favorable risk-reward setup.

Edit in a page